News

According to the average brokerage recommendation (ABR), one should invest in Viking Therapeutics (VKTX). It is debatable whether this highly sought-after metric is effective because Wall Street ...
Viking Therapeutics is quickly emerging as one of the most promising biotech stocks in the small-cap Russell 2000 index. With Wall Street analysts projecting a potential upside of ...
Trump Media's Truth Social plans a Bitcoin ETF launch, backed by SEC approval. Learn about its growth strategies and investor opportunities.
We recently published a list of Investors Are Gobbling Up Shares of These 10 Firms. In this article, we are going to take a ...
Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...
According to TipRanks.com, Ulz is a 1-star analyst with an average return of -0.7% and a 42.5% success rate. Ulz covers the Healthcare sector, focusing on stocks such as Aardvark Therapeutics, Inc., ...